Antiviral therapy in acute viral hepatitis B: why and when
-
* Corresponding author: Alessandro Perrella alexperrel@virgilio.it
1 VII Department of Infectious Diseases and Immunology, D Cotugno Hospital, Naples, Italy
2 Liver Unit, A Cardarelli Hospital, Naples, Italy
Infectious Agents and Cancer 2009, 4:5 doi:10.1186/1750-9378-4-5
The electronic version of this article is the complete one and can be found online at: http://www.infectagentscancer.com/content/4/1/5
| Received: | 27 March 2009 |
| Accepted: | 1 April 2009 |
| Published: | 1 April 2009 |
© 2009 Morelli et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Correction to Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O: Antiviral therapy in acute viral hepatitis B: why and when. Infectious Agents and Cancer 2009, 4:2.
Correction
After publication of this work [1], we noted that we inadvertently failed to include the complete list of all coauthors. The full list of authors has now been corrected here and the Authors' contributions and Competing interests section modified accordingly (see below).
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
GM, AP were involved in preparation of data analysis, preparation of the manuscript and study coordination; CS, PB, VR, AM were involved in clinical investigation; OP was involved in idea writing of the manuscript, principal investigator and responsible for the study.
References
-
Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O: Antiviral therapy in acute viral hepatitis B: why and when.
Infectious Agents and Cancer 2009, 4:2. BioMed Central Full Text